Children's eyes are uniquely vulnerable. Unlike adults, a child's eyeball continues to grow and develop, making traditional vitreous replacement therapies particularly problematic.
Silicone oil has long been used to replace the vitreous humor after severe retinal or ocular trauma. However, in children, this approach frequently leads to:
Silicone oil emulsification — the oil breaks down over time, causing inflammation and elevated intraocular pressure
Silicone oil-dependent eyes — repeated surgeries become necessary, with each procedure adding risk
Progressive eyeball atrophy — the eye shrinks, leading to facial asymmetry as the child grows
High enucleation rates — in severe, complex cases, many hospitals worldwide ultimately recommend removing the eye
For families navigating multiple failed surgeries, the emotional and medical toll is immense. Until recently, there was no ideal alternative.
The Foldable Capsular Vitreous Body (FCVB) is an original Chinese medical technology designed to address the limitations of silicone oil tamponade. Approved for clinical use, FCVB represents a significant advance in vitreous replacement therapy.
Unlike free-flowing silicone oil, FCVB is a capsular implant that:
Is folded and inserted through a small surgical incision
Unfolds inside the eye to provide stable, long-term vitreous support
Contains the tamponade material within a biocompatible capsule
Maintains consistent intraocular pressure and retinal support
This encapsulated design dramatically reduces the complications associated with free silicone oil while providing the structural support needed to prevent eyeball atrophy.
At the forefront of this medical revolution is Professor Liang Tianwei, Director of Ophthalmology at Beijing Jingdu Children's Hospital and one of China's earliest and most experienced specialists in FCVB implantation for children.
With decades of dedicated experience in pediatric ocular trauma and vitreoretinal disease, Professor Liang has:
Performed hundreds of complex eye-preservation surgeries in children
Treated numerous international referral cases that other institutions deemed untreatable
Pioneered personalized FCVB implantation protocols specifically adapted for pediatric anatomy
Presented clinical outcomes at COA (Chinese Ophthalmological Association) international conferences, sharing China's approach with the global ophthalmology community
Professor Liang's expertise lies not only in surgical skill but in the careful, individualized assessment each child requires. No two pediatric eye injuries are identical, and treatment planning demands deep experience with children's developing ocular structures.
Beijing Jingdu Children's Hospital accepts pediatric patients with a wide range of severe ocular conditions, including:
| Condition | Description |
|---|---|
| Penetrating eye injuries | Pencil, wire, or sharp object trauma to the globe |
| Ruptured globe | Blunt trauma from accidents, including motor vehicle injuries |
| Endophthalmitis | Severe intraocular infection following trauma |
| Silicone oil-dependent eyes | Eyes requiring repeated silicone oil procedures |
| Early eyeball atrophy | Progressive shrinkage after multiple surgeries |
| Complex retinal detachment | Trauma-related retinal complications in children |
Many of our patients arrive after receiving recommendations for enucleation from other hospitals — in China and abroad. For these families, FCVB surgery often represents their last hope for preserving the eye.
The encapsulated structure provides consistent, long-term support to maintain the eye's shape and volume, preventing progressive atrophy.
FCVB's design and surgical technique can be tailored to the smaller, developing pediatric eye — a critical advantage that traditional silicone oil cannot match.
By containing the tamponade material within a capsule, FCVB reduces emulsification, inflammation, and pressure-related complications common with free silicone oil.
Unlike silicone oil patients who must maintain face-down positioning for extended periods, FCVB patients avoid this uncomfortable and difficult requirement — especially challenging for young children.
By maintaining eyeball volume and structure, FCVB helps prevent the facial asymmetry that can result from eye atrophy or removal during a child's growth.
Beijing Jingdu Children's Hospital has become a trusted destination for families from around the world. We understand that traveling abroad for medical care involves unique challenges, and we provide comprehensive support through our dedicated international patient services:
Multilingual coordination — English-language medical liaison support
Remote case evaluation — initial assessment based on medical records and imaging before travel
One-stop international patient pathway — streamlined scheduling, admission, and follow-up
Family-centered care — accommodation guidance and logistical support for accompanying family members
Postoperative follow-up coordination — guidance for ongoing care after returning home
Families from multiple countries have traveled to Beijing specifically for Professor Liang's FCVB expertise, making our hospital one of the world's most active centers for pediatric FCVB surgery.
China's original FCVB technology — access to a breakthrough treatment developed and refined in China
World-leading pediatric expertise — Professor Liang Tianwei's unparalleled experience with complex pediatric cases
Dedicated pediatric platform — a hospital built around children's unique medical and developmental needs
Proven international track record — successful outcomes for patients referred from overseas institutions
Comprehensive care continuum — from initial evaluation through surgery and long-term follow-up
Severe eye trauma in children should not automatically mean losing an eye. With FCVB technology and the expertise of Professor Liang Tianwei, many children who face enucleation can instead preserve their eye, maintain normal facial development, and avoid a lifetime of consequences.
If your child has been diagnosed with a severe eye injury, silicone oil dependency, or early eyeball atrophy — and especially if you have been told that eye removal is the only option — we encourage you to seek a second opinion. Our team is ready to evaluate your child's case and discuss whether FCVB surgery may offer hope.
Contact Beijing Jingdu Children's Hospital Ophthalmology Department to learn more about FCVB treatment for pediatric eye trauma.
Disclaimer: This article is for informational purposes and does not constitute medical advice. Treatment outcomes vary by individual case. All surgical decisions should be made in consultation with qualified ophthalmology specialists.
EN
CN